INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $995,487 | +17.4% | 53,694 | -30.0% | 0.00% | 0.0% |
| Q2 2023 | $847,893 | +4.2% | 76,663 | +26.6% | 0.00% | 0.0% |
| Q1 2023 | $813,375 | +305.1% | 60,564 | +273.2% | 0.00% | – |
| Q4 2022 | $200,765 | -82.9% | 16,230 | -80.7% | 0.00% | -100.0% |
| Q3 2022 | $1,174,000 | +29.6% | 84,141 | +51.1% | 0.00% | +100.0% |
| Q1 2022 | $906,000 | +271.3% | 55,700 | +272.3% | 0.00% | – |
| Q4 2021 | $244,000 | +1933.3% | 14,963 | +14863.0% | 0.00% | – |
| Q4 2019 | $12,000 | -99.7% | 100 | -99.8% | 0.00% | -100.0% |
| Q3 2019 | $3,544,000 | +229.7% | 53,400 | +316.8% | 0.03% | +222.2% |
| Q2 2018 | $1,075,000 | -28.5% | 12,812 | -47.6% | 0.01% | -40.0% |
| Q1 2018 | $1,504,000 | +27.1% | 24,444 | +20.7% | 0.02% | +87.5% |
| Q4 2017 | $1,183,000 | +33.4% | 20,251 | +32.6% | 0.01% | 0.0% |
| Q3 2017 | $887,000 | +74.3% | 15,278 | +263.4% | 0.01% | +60.0% |
| Q2 2017 | $509,000 | -45.7% | 4,204 | -49.2% | 0.01% | -54.5% |
| Q1 2017 | $937,000 | +73.5% | 8,282 | +66.8% | 0.01% | +120.0% |
| Q4 2016 | $540,000 | +2.3% | 4,966 | +54.8% | 0.01% | -16.7% |
| Q3 2016 | $528,000 | +41.9% | 3,208 | +23.0% | 0.01% | +50.0% |
| Q2 2016 | $372,000 | +1.6% | 2,608 | +6.5% | 0.00% | 0.0% |
| Q4 2015 | $366,000 | +1364.0% | 2,448 | +1521.2% | 0.00% | – |
| Q3 2015 | $25,000 | -94.3% | 151 | -91.8% | 0.00% | -100.0% |
| Q2 2015 | $442,000 | -87.7% | 1,831 | -85.7% | 0.01% | -89.5% |
| Q1 2015 | $3,605,000 | +2020.6% | 12,784 | +1683.0% | 0.06% | +1800.0% |
| Q3 2014 | $170,000 | -86.0% | 717 | -80.5% | 0.00% | -85.0% |
| Q1 2014 | $1,211,000 | – | 3,671 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |